Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
Author:
Affiliation:
1. Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596, USA
Publisher
Hindawi Limited
Subject
Biochemistry
Link
http://downloads.hindawi.com/journals/bri/2012/832059.pdf
Reference66 articles.
1. Targeted Cancer Therapies in the Twenty-First Century: Lessons From Imatinib
2. Nanotechnology-Based Cancer Therapeutics—Promise and Challenge—Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
3. Selective anticancer drugs
4. Novel agents and new therapeutics in castration-resistant prostate cancer
5. Polymer therapeutics: Clinical applications and challenges for development
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemo-immunotherapy by nanoliposomal epacadostat and docetaxel combination to IDO1 inhibition and tumor microenvironment suppression;International Immunopharmacology;2024-08
2. Ph-Sensitive Docetaxel-Loaded Chitosan/Thiolated Hyaluronic Acid Polymeric Nanoparticles for Colorectal Cancer;Nanomedicine;2024-03-29
3. Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer;PLOS ONE;2024-02-27
4. Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer;Exploration of Targeted Anti-tumor Therapy;2023-12-20
5. Impact of Chemotherapeutic Stress Depends on The Nature of Breast Cancer Spheroid and Induce Behavioral Plasticity to Resistant Population;Advanced Biology;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3